Search Results - "YOSHIDA, J"

Refine Results
  1. 1

    Applications of patient-derived tumor xenograft models and tumor organoids by Yoshida, Go J

    Published in Journal of hematology and oncology (07-01-2020)
    “…Patient-derived tumor xenografts (PDXs), in which tumor fragments surgically dissected from cancer patients are directly transplanted into immunodeficient…”
    Get full text
    Journal Article
  2. 2

    Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways by Yoshida, Go J

    “…Accumulating evidence indicates that intratumoral heterogeneity contributes to the development of resistance to anticancer therapeutics. Fibroblasts, which are…”
    Get full text
    Journal Article
  3. 3

    Metabolic reprogramming: the emerging concept and associated therapeutic strategies by Yoshida, Go J

    “…Tumor tissue is composed of cancer cells and surrounding stromal cells with diverse genetic/epigenetic backgrounds, a situation known as intra-tumoral…”
    Get full text
    Journal Article
  4. 4

    Emerging roles of Myc in stem cell biology and novel tumor therapies by Yoshida, Go J

    “…The pathophysiological roles and the therapeutic potentials of Myc family are reviewed in this article. The physiological functions and molecular machineries…”
    Get full text
    Journal Article
  5. 5

    Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment by Yoshida, Go J

    Published in Journal of hematology and oncology (09-03-2017)
    “…The 2016 Nobel Prize in Physiology or Medicine was awarded to the researcher that discovered autophagy, which is an evolutionally conserved catabolic process…”
    Get full text
    Journal Article
  6. 6

    Therapeutic strategies targeting cancer stem cells by Yoshida, Go J., Saya, Hideyuki

    Published in Cancer science (01-01-2016)
    “…Cancer stem cells (CSCs) are undifferentiated cancer cells with a high tumorigenic activity, the ability to undergo self‐renewal, and a multilineage…”
    Get full text
    Journal Article
  7. 7

    Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies by Yoshida, Go J, Azuma, Arata, Miura, Yukiko, Orimo, Akira

    “…Neoplastic epithelial cells coexist in carcinomas with various non-neoplastic stromal cells, together creating the tumor microenvironment. There is a growing…”
    Get full text
    Journal Article
  8. 8

    Study on Reduction of Quench Recovery Time by Inductive Energy Extraction by Ebara, Y., Yoshida, J.

    “…Superconducting coils can generate high magnetic fields and are used in many applications in medicine, industry and research. A superconducting coil stores…”
    Get full text
    Journal Article
  9. 9

    Beyond the Warburg Effect: N-Myc Contributes to Metabolic Reprogramming in Cancer Cells by Yoshida, Go J.

    Published in Frontiers in oncology (27-05-2020)
    “…Cancer cells generate large amounts of lactate derived from glucose regardless of the available oxygen level. Cancer cells finely control ATP synthesis by…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Emerging role of epithelial-mesenchymal transition in hepatic cancer by Yoshida, Go J

    “…Accumulating evidence suggests that the phenomenon of epithelial-mesenchymal-transition (EMT) plays a fundamental role in the tumor development. Several…”
    Get full text
    Journal Article
  13. 13

    Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation by Yoshida, Go J., Saya, Hideyuki

    “…•CD44 variant8–10 and c-Myc are inversely expressed in gastric cancer cells.•Redox-stress enhances c-Myc expression via canonical Wnt signal.•CD44v, but not…”
    Get full text
    Journal Article
  14. 14

    The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells by Yoshida, Go J

    Published in Metabolites (02-01-2021)
    “…There is a growing body of evidence that metabolic reprogramming contributes to the acquisition and maintenance of robustness associated with malignancy. The…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Molecular pathology underlying the robustness of cancer stem cells by Yoshida, Go J., Saya, Hideyuki

    Published in Regenerative therapy (01-06-2021)
    “…Intratumoral heterogeneity is tightly associated with the failure of anticancer treatment modalities including conventional chemotherapy, radiation therapy,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non–Small Cell Lung Cancer by Lam, Alexander, Yoshida, Emi J., Bui, Kevin, Fernando, Dayantha, Nelson, Kari, Abi-Jaoudeh, Nadine

    “…To compare overall survival (OS) after radiofrequency (RF) ablation and stereotactic body radiotherapy (SBRT) at high-volume centers in patients with…”
    Get full text
    Journal Article
  19. 19

    EpCAM expression in the prostate cancer makes the difference in the response to growth factors by Yoshida, Go J., Saya, Hideyuki

    “…•EpCAM is heterogeneously expressed in prostate cancer both in vitro and in vivo.•mTOR signaling is differentially regulated in EpCAM-high and -low…”
    Get full text
    Journal Article
  20. 20